Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis ; volume:103 ; number:8 ; day:25 ; month:6 ; year:2024 ; pages:3071-3081 ; date:8.2024
Annals of hematology ; 103, Heft 8 (25.6.2024), 3071-3081, 8.2024

Creator
Denk, Alexander
Edinger, Matthias
Weber, Daniela
Holler, Ernst
Fante, Matthias
Meedt, Elisabeth
Gunes, Sibel
Poeck, Hendrik
Mittermaier, Cornelia
Herr, Wolfgang
Wolff, Daniel
Contributor
SpringerLink (Online service)

DOI
10.1007/s00277-024-05696-x
URN
urn:nbn:de:101:1-2410122109225.183909587907
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Denk, Alexander
  • Edinger, Matthias
  • Weber, Daniela
  • Holler, Ernst
  • Fante, Matthias
  • Meedt, Elisabeth
  • Gunes, Sibel
  • Poeck, Hendrik
  • Mittermaier, Cornelia
  • Herr, Wolfgang
  • Wolff, Daniel
  • SpringerLink (Online service)

Other Objects (12)

Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease

Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease

Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis

Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis

Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study

Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study

Angiogenesis in Graft-versus-Host Disease

Angiogenesis in Graft-versus-Host Disease

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease: A Giant Leap-To Start with Baby Steps

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease: A Giant Leap-To Start with Baby Steps

Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience

Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience

Endothelial dysfunction during Graft-versus-Host Disease

Endothelial dysfunction during Graft-versus-Host Disease

Prognosefaktoren der chronischen Graft-versus-Host Krankheit

Hochschulschrift

Prognosefaktoren der chronischen Graft-versus-Host Krankheit

Ruxolitinib in Glucocorticoid Refractory Chronic Graft versus Host Disease

Ruxolitinib in Glucocorticoid Refractory Chronic Graft versus Host Disease

Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients

Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients

Acute Graft-Versus-Host Disease of the Esophagus

Acute Graft-Versus-Host Disease of the Esophagus

A Case of Colonic Graft-versus-Host Disease

A Case of Colonic Graft-versus-Host Disease

Related objects